These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32941853)

  • 21. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
    Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of co-expressed mu- and delta-opioid receptors in transfected rat pituitary GH(3) cells.
    Martin NA; Prather PL
    Mol Pharmacol; 2001 Apr; 59(4):774-83. PubMed ID: 11259622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
    Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
    Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward.
    Duvauchelle CL; Fleming SM; Kornetsky C
    Eur J Pharmacol; 1996 Dec; 316(2-3):137-43. PubMed ID: 8982679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of mu- and delta-opioid receptors causes presynaptic inhibition of glutamatergic excitation in neocortical neurons.
    Ostermeier AM; Schlösser B; Schwender D; Sutor B
    Anesthesiology; 2000 Oct; 93(4):1053-63. PubMed ID: 11020761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcohol.
    Shrivastava P; Cabrera MA; Chastain LG; Boyadjieva NI; Jabbar S; Franklin T; Sarkar DK
    J Neuroinflammation; 2017 Apr; 14(1):83. PubMed ID: 28407740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
    Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
    Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
    Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
    Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons.
    Zhu W; Pan ZZ
    Neuroscience; 2005; 133(1):97-103. PubMed ID: 15893634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats.
    Ragnauth A; Moroz M; Bodnar RJ
    Brain Res; 2000 Sep; 876(1-2):76-87. PubMed ID: 10973595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration.
    García-Sevilla JA; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R
    Neuropharmacology; 2004 Mar; 46(4):519-30. PubMed ID: 14975676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMDA Receptors on Dopaminoceptive Neurons Are Essential for Drug-Induced Conditioned Place Preference.
    Sikora M; Tokarski K; Bobula B; Zajdel J; Jastrzębska K; Cieślak PE; Zygmunt M; Sowa J; Smutek M; Kamińska K; Gołembiowska K; Engblom D; Hess G; Przewlocki R; Rodriguez Parkitna J
    eNeuro; 2016; 3(3):. PubMed ID: 27294197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mu and delta opioids but not kappa opioid inhibit voltage-activated Ba2+ currents in neuronal F-11 cell.
    Nah SY; Unteutsch A; Bunzow JR; Cook SP; Beacham DW; Grandy DK
    Brain Res; 1997 Aug; 766(1-2):66-71. PubMed ID: 9359588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion.
    Narita M; Mizuo K; Mizoguchi H; Sakata M; Narita M; Tseng LF; Suzuki T
    J Neurosci; 2003 Feb; 23(3):1006-12. PubMed ID: 12574430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen.
    Noble F; Cox BM
    J Neurochem; 1995 Jul; 65(1):125-33. PubMed ID: 7790855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excitatory amino acid receptor subtype agonists induce feeding in the nucleus accumbens shell in rats: opioid antagonist actions and interactions with mu-opioid agonists.
    Echo JA; Lamonte N; Christian G; Znamensky V; Ackerman TF; Bodnar RJ
    Brain Res; 2001 Dec; 921(1-2):86-97. PubMed ID: 11720714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
    Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.